BBOX1-AS1 promotes gastric cardia adenocarcinoma progression via interaction with CtBP2 to facilitate the epithelial-mesenchymal transition process

被引:0
作者
Zou, Wenxu [1 ]
Yin, Qing [1 ]
Guo, Wei [1 ]
Dong, Zhiming [1 ]
Guo, Yanli [1 ]
机构
[1] Hebei Med Univ, Hosp 4, Hebei Canc Inst, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China
关键词
BBOX1-AS1; CtBP2; epithelial mesenchymal transition; gastric cardia adenocarcinoma; Wnt/beta-catenin signaling pathway; E-CADHERIN; TRANSCRIPTION; COREPRESSOR; ESOPHAGUS; CARCINOMA; APOPTOSIS; JUNCTION; CATENIN; CANCER; CELLS;
D O I
10.1111/cas.16350
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is recognized that lncRNA BBOX1-AS1 exerts a crucial oncogenic property in several cancer types. However, the functions and underlying mechanisms of BBOX1-AS1 in the epithelial-mesenchymal transition (EMT) process of gastric cardia adenocarcinoma (GCA) have remained unclarified. The findings of this study demonstrated that GCA tissues had elevated BBOX1-AS1 expression levels, which was associated with a worse prognosis in GCA patients. BBOX1-AS1 dramatically enhanced cell proliferation, invasion, and TGF-beta 1-induced the EMT process in vitro. Further mechanism analysis revealed that BBOX1-AS1 could combine with CtBP2 and strengthen the interaction of CtBP2 and ZEB1. BBOX1-AS1 might regulate the E-cadherin expression through CtBP2/ZEB1 transcriptional complex-mediated transcriptional repression, further affecting the activation of the Wnt/beta-catenin pathway and the EMT process. Overall, our findings demonstrate that BBOX1-AS1 might act as an lncRNA associated with EMT for facilitating GCA advancement via interaction with CtBP2 to facilitate the activation of Wnt/beta-catenin pathway and the EMT process, which indicated that it might function as an exploitable treatment target for GCA patients.
引用
收藏
页码:3875 / 3889
页数:15
相关论文
共 43 条
  • [1] The Wnt/β-catenin pathway in ovarian cancer: A review
    Arend, Rebecca C.
    Londono-Joshi, Angelina I.
    Straughn, J. Michael, Jr.
    Buchsbaum, Donald J.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 131 (03) : 772 - 779
  • [2] Global burden of oesophageal and gastric cancer by histology and subsite in 2018
    Arnold, Melina
    Ferlay, Jacques
    Henegouwen, Mark I. van Berge
    Soerjomataram, Isabelle
    [J]. GUT, 2020, 69 (09) : 1564 - 1571
  • [3] Bai Y., 2020, CANCERS, V12, P12
  • [4] RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer
    Bracken, Cameron P.
    Goodall, Gregory J.
    Gregory, Philip A.
    [J]. SEMINARS IN CANCER BIOLOGY, 2024, 102 : 4 - 16
  • [5] Epidemiology and Risk Factors for Gastroesophageal Junction Tumors: Understanding the Rising Incidence of This Disease
    Buas, Matthew F.
    Vaughan, Thomas L.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2013, 23 (01) : 3 - 9
  • [6] CtBP-a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinoma
    Chawla, Ayesha T.
    Chougoni, Kranthi Kumar
    Joshi, Prashant J.
    Cororaton, Agnes D.
    Memari, Patrick
    Stansfield, John C.
    Park, Haemin
    Seth, Rashmi
    Szomju, Barbara
    Sima, Adam P.
    Idowu, Michael O.
    Ellis, Keith C.
    Grossman, Steven R.
    [J]. ONCOGENESIS, 2019, 8 (10)
  • [7] CtBP, an unconventional transcriptional corepressor in development and oncogenesis
    Chinnadurai, G
    [J]. MOLECULAR CELL, 2002, 9 (02) : 213 - 224
  • [8] CtBP determines ovarian cancer cell fate through repression of death receptors
    Ding, Boxiao
    Yuan, Fang
    Damle, Priyadarshan K.
    Litovchick, Larisa
    Drapkin, Ronny
    Grossman, Steven R.
    [J]. CELL DEATH & DISEASE, 2020, 11 (04)
  • [9] C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs
    Grooteclaes, M
    Deveraux, Q
    Hildebrand, J
    Zhang, QH
    Goodman, RH
    Frisch, SM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (08) : 4568 - 4573
  • [10] Evidence for a function of CtBP in epithelial gene regulation and anoikis
    Grooteclaes, ML
    Frisch, SM
    [J]. ONCOGENE, 2000, 19 (33) : 3823 - 3828